Savitha Subramanian is an Endocrinology/Metabolic physician affiliated with Gates Foundation. OpenAlex indexes 88 publications with 3,304 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
5 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
51.2%Insulin Analog23.8%Lantus Solostar36%Novolog Flexpen21%Humalog Kwikpen U-10018%Novolog7%Basaglar Kwikpen U-1006%Insulin Lispro Kwikpen U-1006%Lantus6%Part D<11 patientsBiguanide (metformin)10.3%Metformin Hcl65%Metformin Hcl Er36%Part D≥18 patients+ 3 more classes in this area
Cardiovascular
43.8%PCSK9 Inhibitor16.4%Repatha Sureclick61%Praluent Pen39%Part D≥21 patientsStatin14.1%Rosuvastatin Calcium56%Atorvastatin Calcium45%Part D≥25 patients+ 5 more classes in this area
Hormonal (systemic)
5.1%l-Thyroxine5.1%Levothyroxine Sodium100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Approach to Lipid Management in the Patient With Diabetes
The Journal of Clinical Endocrinology & Metabolism
2025 - Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care
Journal of the Academy of Nutrition and Dietetics
2024 - sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
Hepatology Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”